Module 3.3 – Real-time phylogenetics with UShER
This module provides an introduction to UShER and an easy to use web portal for fast phylogenetic tree calculation.
This video can also be viewed at
Related Articles
Why are Gowns, Gloves, and Eye Protection Recommended for COVID-19?
Respirators are a common type of personal protective equipment (PPE) – but not the only one. Gowns, gloves, goggles, and face shields are other kinds of PPE that Latino and all frontline healthcare workers use to help the spread of germs and viruses, including the virus that causes COVID-19. Gowns In healthcare, gowns are worn …
The post Why are Gowns, Gloves, and Eye Protection Recommended for COVID-19? appeared first on Salud America.
Toolkit: Module 3.3
This module provides an introduction to UShER and an easy to use web portal for fast phylogenetic tree calculation. Comments on this video are allowed…
National Health Agency News
National Health Agency Sources Telehealth & Health Equity: Addressing Health Disparities during the COVID-19 Pandemic September 21, 2020 No Comments During this COCA Call, presenters…
Get Moving Toward a Healthier You!
Physical inactivity is one of the leading risk factors for many diseases, including cancer, according to the World Health Organization (WHO). Physical inactivity has a 25.3% prevalence in the US, where about 60% of adults say they are physically inactive as of 2020, according to the CDC. That’s why the CDC launched a campaign to …
The post Get Moving Toward a Healthier You! appeared first on Salud America.
CDC Report: US Tuberculosis Cases Increased in 2022
US tuberculosis (TB) cases increased for the second straight year in 2022, according to new data from the Centers for Disease Control and Prevention (CDC) Certain racial and ethnic groups, including Latinos, saw considerable increases in TB infections. Let’s explore what this data means for Latinos, and why this population is more vulnerable to TB …
The post CDC Report: US Tuberculosis Cases Increased in 2022 appeared first on Salud America.
Responses